Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
05/18/2010 | US7718180 Immunizing compositions comprising nucleic acids encoding the HIV-1 matrix protein myristate binding site |
05/18/2010 | US7718163 Includes additive material on the surfaces of the carrier particles to promote the release of the active particles from the carrier particles on actuation of the inhaler; an inhalant includes crystalline milk sugar carrier,leucine additive and beclomethasone dipropionate inhalant |
05/18/2010 | US7718162 Medicinal aerosol compositions with a functionalized polyethyleneglycol excipient |
05/18/2010 | US7718160 Radiolabeled compounds and liposomes and their method of making and using same |
05/18/2010 | US7718157 Targeted lipid particles |
05/18/2010 | US7718128 Kit including a cucurbit(6-10)uril derivative bound to a first material; and a second component that is a ligand that non-covalently binds to the cucurbituril bound to a second material; materials include biomolecules, drugs, catalysts, chromophores, fluorescent materials, phosphors, and cyclophanes |
05/18/2010 | US7717903 Operating an infusion pump system |
05/18/2010 | US7717889 Disinfectant delivery system and method of providing alcohol free disinfection |
05/18/2010 | CA2555429C Stable injectable diclofenac compositions |
05/18/2010 | CA2509715C Improved thickened beverages for dysphagia |
05/18/2010 | CA2473205C Orodispersible pharmaceutical composition comprising perindopril |
05/18/2010 | CA2455226C Compositions comprising an o/w emulsion containing conjugated linoleic acid |
05/18/2010 | CA2437754C Tablets quickly disintegrated in oral cavity |
05/18/2010 | CA2424619C Method for coating fine particles with lipid membrane |
05/18/2010 | CA2401498C New self emulsifying drug delivery system |
05/18/2010 | CA2387536C Rate-controlled particles |
05/18/2010 | CA2358634C Removable filter for slurry hydrocarbon synthesis process |
05/18/2010 | CA2340546C Soft capsules comprising polymers of vinyl esters and polyethers, the use and production thereof |
05/18/2010 | CA2171266C Stable transglutaminase preparations and processes for producing them |
05/18/2010 | CA2131797C Condensed indole derivatives as 5ht4-receptor antagonists |
05/14/2010 | WO2010054326A2 C-terminal fragments of glucagon-like peptide-1 (glp-1) |
05/14/2010 | WO2010054316A2 Endothelium mimicking nanomatrix |
05/14/2010 | WO2010054314A1 Method of inputting data into an infusion pump |
05/14/2010 | WO2010054238A1 Factor viii formulations |
05/14/2010 | WO2010054093A1 Formulations for the treatment of acute herpes zoster pain |
05/14/2010 | WO2010054083A2 Inhalation formulation for treating and prophylatic use in bacteria, mycobacterial and fungal respiratory infections |
05/14/2010 | WO2010053763A1 Tumor-targeting peptides and uses thereof |
05/14/2010 | WO2010053492A1 Shelf stable capsules |
05/14/2010 | WO2010053489A1 Fusogenic properties of saposin c and related proteins and peptides for application to transmembrane drug delivery systems |
05/14/2010 | WO2010053343A1 Process for obtaining a composition of rosuvastatin calcium and product obtained |
05/14/2010 | WO2010053337A2 Slow-release particle and a production method therefor |
05/14/2010 | WO2010053335A2 Method for producing powder containing nanoparticles of insoluble drug, powder produced thereby and pharmaceutical composition containing same |
05/14/2010 | WO2010053306A2 Pharmaceutical composition for the controlled release of methylphenidate |
05/14/2010 | WO2010053101A1 Eye drop having high intraocular migration properties, fluorescent imaging agent, and methods for producing same |
05/14/2010 | WO2010053017A1 Ultraviolet-absorbing composition, cosmetics and pharmaceutical formulations using the same, and ultraviolet blocking method |
05/14/2010 | WO2010052896A1 Preparation for local administration containing fluticasone propionate |
05/14/2010 | WO2010052879A1 Aqueous composition containing follicle-stimulating hormone |
05/14/2010 | WO2010052727A1 High performance film coating compositions |
05/14/2010 | WO2010052692A1 A transfer device for transferring a substance between the device and a subject |
05/14/2010 | WO2010052665A2 Gold nanoparticles coated with polyelectrolytes and use thereof as medicament for the treatment of neurodegenerative diseases caused by protein aggregates |
05/14/2010 | WO2010052582A1 Medical devices with definable porosity produced by bacterial polymer bio-synthesis |
05/14/2010 | WO2010052575A2 Ngna compositions and methods of use |
05/14/2010 | WO2010052491A2 Collar protector |
05/14/2010 | WO2010052430A2 Heat sterilised injectable composition of hyaluronic acid or one of the salts thereof, polyols and lidocaine |
05/14/2010 | WO2010052326A1 Small interfering rna delivery |
05/14/2010 | WO2010052281A1 Energizing chewing gum |
05/14/2010 | WO2010051918A2 Compositions containing lipid micro- or nanoparticles for the enhancement of the dermal action of solid particles |
05/14/2010 | WO2010051792A1 Use of microtablets as food additive and feed additive |
05/14/2010 | WO2010051683A1 A composition useful for treating acute enteritis and diarrhea |
05/14/2010 | WO2010051664A1 7h-imidazo[1,20-a]pyrano[2,3-c]pyridine derivations and the use thereof |
05/14/2010 | WO2010037066A3 Dosage units of 3-(6-(1-(2,2-difluorobenzo [d] [1,3] dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid |
05/14/2010 | WO2010034089A3 Preparation method of injectable biodegradable polymer |
05/14/2010 | WO2010032141A3 Non-typeable haemophilus influenzae vaccines and their uses |
05/14/2010 | WO2010027603A3 Compositions comprising solid particles encapsulated in a cross-linked silicone matrix, and methods of making the same |
05/14/2010 | WO2010017918A3 Amorphous ambrisentan |
05/14/2010 | WO2010016711A3 Aroma therapy patch |
05/14/2010 | WO2010013224A4 Curcumin nanoparticles and methods of producing the same |
05/14/2010 | WO2010012408A3 Microemulsion |
05/14/2010 | WO2010011605A3 Controlled-release otic structure modulating and innate immune system modulating compositions and methods for the treatment of otic disorders |
05/14/2010 | WO2010011343A3 Methods for treating viral disorders |
05/14/2010 | WO2010008876A3 Method for preparation of micellar hybrid nanoparticles for therapeutic and diagnostic applications and compositions thereof |
05/14/2010 | WO2010008519A3 In vitro diagnostic markers comprising carbon nanoparticles and kits |
05/14/2010 | WO2010008244A3 Pharmaceutical preparation |
05/14/2010 | WO2009152167A3 Delivery of therapeutics |
05/14/2010 | WO2009120389A8 Oral and injectable formulations of tetracycline compounds |
05/14/2010 | WO2009112169A3 Suspension formula for carbon adsorbents |
05/14/2010 | WO2009106824A3 Pharmaceutical formulations with a taste masking coating |
05/14/2010 | WO2009104054A8 Pharmaceutical compositions containing water-soluble derivatives of propofol and methods of administering same via pulmonary administration |
05/14/2010 | WO2009095681A3 Suspension formulations |
05/14/2010 | WO2009083664A8 Novel taxoid-based compositions |
05/14/2010 | CA2744820A1 Process for obtaining a rosuvastatin calcium composition and obtained product |
05/14/2010 | CA2742915A1 Gold nanoparticles coated with polyelectrolytes and use thereof as medicament for the treatment of neurodegenerative diseases caused by protein aggregates |
05/14/2010 | CA2742831A1 Fusogenic properties of saposin c and related proteins and peptides for application to transmembrane drug delivery systems |
05/14/2010 | CA2742782A1 Endothelium mimicking nanomatrix |
05/14/2010 | CA2742759A1 Dry granulation in a gas stream |
05/14/2010 | CA2742680A1 Pharmaceutical compositions for release control of methylphenidate |
05/14/2010 | CA2742659A1 Aqueous composition containing follicle-stimulating hormone |
05/14/2010 | CA2742603A1 Formulations for the treatment of acute herpes zoster pain |
05/14/2010 | CA2742367A1 Shelf stable capsules |
05/14/2010 | CA2742328A1 Factor viii formulations |
05/14/2010 | CA2742099A1 Heat sterilised injectable composition of hyaluronic acid or one of the salts thereof, polyols and lidocaine |
05/14/2010 | CA2741515A1 Medical devices with tuneable porosity during bacterial polymer bio-synthesis |
05/13/2010 | US20100121315 Personal accessory for use with a pill |
05/13/2010 | US20100121308 Devices and methods for delivering therapeutic substances for the treatment of sinusitis and other disorders |
05/13/2010 | US20100121304 Multifunctional Acrylate Skin-Adhesive Composition |
05/13/2010 | US20100121261 Anti-Adhesion Spraying |
05/13/2010 | US20100121244 Devices and methods for the delivery of molecular sieve materials for the formation of blood clots |
05/13/2010 | US20100120877 Additional therapeutic use |
05/13/2010 | US20100120782 Endoparasiticidal gel composition |
05/13/2010 | US20100120734 Formoterol/steroid bronchodilating compositions and methods of use thereof |
05/13/2010 | US20100119694 Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof |
05/13/2010 | US20100119692 Modifying undesirable tastes |
05/13/2010 | US20100119621 Process for preparing oral calcium compositions |
05/13/2010 | US20100119612 Nanoparticles comprising non-crystalline drug |
05/13/2010 | US20100119611 Delivery of a Bioactive Material |
05/13/2010 | US20100119610 Packaged pegylated gold nanoparticles |
05/13/2010 | US20100119609 Methods, compositions, and formulations for the treatment of thyroid eye disease |
05/13/2010 | US20100119608 Synthesis of pH-sensitive, Acid-Stable Metal-Binding Nanoparticles |
05/13/2010 | US20100119607 Bioenhanced compositions |
05/13/2010 | US20100119606 Processes and apparatus for extraction of active substances and enriched extracts from natural products |